Hmmm Laura Soucek's OMOMYC targetted KRAS driven lung cancer in mice ? I never picked up the KRAS synergies there between both groups. Interesting that Phoremost put the final ink to paper in the deal a week after pilot study data was released.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3605464/
Hmmm Laura Soucek's OMOMYC targetted KRAS driven lung cancer in...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.27 |
Change
0.005(0.40%) |
Mkt cap ! $740.7M | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.29 | $1.27 | $406.0K | 319.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 13987 | $1.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.29 | 1380 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |